Replies to post #844 on PDS Biotechnology Corp (PDSB)

[StocktraderDK]

$PDSB news...

PDS Biotechnology Corporation (Nasdaq: $PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Frank Bedu-Addo, CEO of PDS Biotech, will present at the H.C. Wainwright Global Life Sciences Conference being held from March 9-10, and at the 31st Annual Oppenheimer Healthcare Conference being held from March 16-18. Both conferences are being hosted virtually.
H.C. Wainwright & Co. Global Life Sciences Conference
Date: Presentation Available On-Demand March 9-10, 2021
Registration: Click Here

31st Annual Oppenheimer Healthcare Conference
Date: March 16, 2021 at 1:10 PM Eastern Time
Registration: Click Here